載入...
Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12-month interim analysis of ROCK-J, a post-marketing surveillance study
BACKGROUND: Ripasudil is approved in Japan for glaucoma or ocular hypertension (OH) when other treatments are ineffective or cannot be administered. Its long-term safety and efficacy are being examined in a post-marketing surveillance study; 12-month data are described here. METHODS: This prospectiv...
Na minha lista:
| 發表在: | BMC Ophthalmol |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7350764/ https://ncbi.nlm.nih.gov/pubmed/32646383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-020-01490-1 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|